發送短信 : Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

 _    _    _    _     _  __    _____     ______  
| || | || | || | ||  | |/ //  |  ___||  /_____// 
| || | || | || | ||  | ' //   | ||__    `____ `  
| \\_/ || | \\_/ ||  | . \\   | ||__    /___//   
 \____//   \____//   |_|\_\\  |_____||  `__ `    
  `---`     `---`    `-` --`  `-----`   /_//     
                                        `-`